• bitcoinBitcoin(BTC)$63,953.00-1.62%
  • ethereumEthereum(ETH)$1,792.86-1.53%
  • tetherTether(USDT)$1.00-0.01%
  • binancecoinBNB(BNB)$588.49-0.89%
  • usd-coinUSDC(USDC)$1.000.00%
  • rippleXRP(XRP)$0.980.98%
  • solanaSolana(SOL)$74.160.40%
  • tronTRON(TRX)$0.3092841.11%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.010.00%
  • HyperliquidHyperliquid(HYPE)$68.52-1.45%
  • zcashZcash(ZEC)$932.82-1.82%
  • moneroMonero(XMR)$503.33-2.77%
  • dogecoinDogecoin(DOGE)$0.059221-0.51%
  • leo-tokenLEO Token(LEO)$9.280.05%
  • USDSUSDS(USDS)$1.000.01%
  • whitebitWhiteBIT Coin(WBT)$61.76-1.60%
  • chainlinkChainlink(LINK)$9.13-1.94%
  • cardanoCardano(ADA)$0.152959-1.49%
  • stellarStellar(XLM)$0.140385-0.47%
  • Ethena USDeEthena USDe(USDE)$1.00-0.03%
  • daiDai(DAI)$1.000.00%
  • nearNEAR Protocol(NEAR)$3.332.02%
  • bitcoin-cashBitcoin Cash(BCH)$207.88-2.28%
  • litecoinLitecoin(LTC)$44.04-2.64%
  • CantonCanton(CC)$0.083304-0.53%
  • RainRain(RAIN)$0.004659-15.72%
  • avalanche-2Avalanche(AVAX)$7.09-2.34%
  • uniswapUniswap(UNI)$5.21-4.02%
  • tether-goldTether Gold(XAUT)$3,751.92-2.36%
  • suiSui(SUI)$0.72-2.37%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.02-0.55%
  • USD1USD1(USD1)$1.000.03%
  • Ripple USDRipple USD(RLUSD)$1.00-0.02%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • hedera-hashgraphHedera(HBAR)$0.057151-2.19%
  • paypal-usdPayPal USD(PYUSD)$1.000.00%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.02%
  • BittensorBittensor(TAO)$194.56-0.33%
  • shiba-inuShiba Inu(SHIB)$0.000004-1.07%
  • crypto-com-chainCronos(CRO)$0.043250-3.41%
  • quant-networkQuant(QNT)$154.14-1.60%
  • MemeCoreMemeCore(M)$0.88-2.38%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.12-0.27%
  • okbOKB(OKB)$87.140.13%
  • aaveAave(AAVE)$110.51-3.17%
  • Falcon USDFalcon USD(USDF)$1.000.04%
  • pax-goldPAX Gold(PAXG)$3,751.70-2.46%
  • United StablesUnited Stables(U)$1.00-0.05%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Mondelez: Buy This Tasty Treat For Growth & Dividends Combined (NASDAQ:MDLZ)

December 9, 2023
in Market & News
Reading Time: 6 mins read
A A
Mondelez: Buy This Tasty Treat For Growth & Dividends Combined (NASDAQ:MDLZ)
ShareShareShareShareShare

Tsuguliev/iStock via Getty Images

The MDLZ Investment Thesis Remains Tempting

We previously covered Hershey Company (NYSE:HSY) in an older article, covering the stock’s excellent growth prospects, attributed to the aggressive M&A activities in order to diversify its confectionary offering with salty snacks.

For this particular article, we will be looking at Mondelez International (NASDAQ:NASDAQ:MDLZ) and sharing our findings about the stock, continuing the theme surrounding the confectionary market.

MDLZ is a stock that does not need any introductions, with its core offerings being a common staple in many household’s pantry, namely Oreo and Philadelphia cream cheese. This is without forgetting the Daim Almond cake and Chocolate Crunch, which is one of our most purchased item from Ikea.

The robust branding power is also why the confectionary/ snack company has been able to report an exemplary FQ3’23 earnings call, with revenues of $9.02B (+6.1% QoQ/ +16.2% YoY) and adj EPS of $0.82 (+7.8% QoQ/ +10.8% YoY).

MDLZ’s Net Revenue Growth

MDLZ's Net Revenue Growth

MDLZ

Most of MDLZ’s tailwinds are attributed to the management’s aggressive pricing actions at +11.9% and a smaller extent to the volume/ mix at +3.8% in the latest quarter, implying its sticky consumer base and excellent pricing power.

Investors may also want to note that its Organic Net Revenue Growth has been mostly attributed to its consistent price hikes since 2019, with a future reversal in prices unlikely.

This implies that the confectionary/ snack company’s top and bottom line expansions will remain robust ahead, as highlighted by the management in the recent earnings call, with “pricing still expected to contribute more than an average year” in 2024.

The robust profitability has directly contributed to the notable improvements in MDLZ’s balance sheet, with a moderating long-term debt of $16.41B (-9.5% QoQ/ -17.1% YoY) by the latest quarter.

This is on top of the sustained share repurchases over the past few years, with 88M shares retired since FY2019, or the equivalent of 6.4% of its float.

This optimistic development has also contributed to MDLZ’s raised FY2023 guidance, with an approximate revenue of $36.05B (+14.5% YoY at the midpoint) and adj EPS of $3.422 (+16% YoY).

This is compared to the previous revenue guidance of +6% YoY and adj EPS growth in the “high single digits” offered in the FQ4’22 earnings call.

Rising Prices For Cocoa & Sugar

Rising Prices For Cocoa & Sugar

Trading Economics & Macro Trends

YOU MAY ALSO LIKE

Man charged after alleged bank robberies in ‘old man’ mask

Grand Theft Auto 6: Reviews come in as worldwide release begins – BBC

There are naturally still headwinds to MDLZ’s near-to-intermediate term prospects, attributed to the rising cocoa prices over the past few years, with the commodity’s future now priced at a record 45Y high of $4.23K per tonne (+7.6% MoM/ +69.2% YoY/ +81.5% from 2019 averages of $2.33K).

The same has been observed with sugar, as prices rose to a 10Y record high of $0.2688 per pound (inline MoM/ +34.4% YoY/ +124% from FY2019 averages of $0.12).

This is on top of the global supply chain issues, rising labor costs, volatile energy costs, and unfavorable FX headwinds, with MDLZ’s gross margins naturally impacted to 37.9% over the last twelve months, compared to FY2019 levels of 40% (+0.1 points YoY)

However, with the PPI already cooling by November 2023, we may see the company’s near-term headwinds moderate, allowing its gross profits to slowly return to its pre-pandemic levels, significantly aided by the “resilient consumer demand over private label alternatives.”

The same has been highlighted in its growing sales in emerging markets by +19% YoY and North America/ Europe by +13% YoY in the latest quarter, despite the consistent price hikes thus far.

MDLZ Valuations

MDLZ Valuations

Seeking Alpha

For now, MDLZ’s FWD P/E valuation of 22.04x does appear to be somewhat frothy compared to its 1Y mean of 21.58x, 5Y pre-pandemic mean of 20.56x, and the sector median of 17.44x.

The Consensus Forward Estimates

The Consensus Forward Estimates

Tikr Terminal

Then again, we believe that the slight premium is warranted, since the consensus estimates that MDLZ may generate an impressive top and bottom line expansion at a CAGR of +6.8% and +9.1% through FY2026.

This is compared to its historical CAGR of +3.3% and +7.2% between FY2016 and FY2022, respectively.

The MDLZ stock appears to be trading near its fair value of $70.35 as well, based on the management’s raised FY2023 adj EPS guidance to $3.422 and its normalized P/E valuation of 20.56x.

In addition, there is still an excellent upside potential of +20.6% to our long-term price target of $85.73, based on the consensus FY2026 adj EPS estimates of $4.17.

MDLZ shareholders may also expect an excellent 4Y Dividend Per Share Growth at a CAGR of +9.3%, compared to its 5Y Growth Rate of +11.42% and the sector median of +5.06%. This is on top of the fairly decent forward dividend yield of 2.38%, compared to the sector median of 2.67%.

So, Is MDLZ Stock A Buy, Sell, or Hold?

MDLZ 10Y Stock Price

MDLZ 10Y Stock Price

Trading View

For now, MDLZ’s 10Y stock returns have been impressive at +106%, otherwise at +151%, if we are to include dividends. These numbers well exceed HSY’s returns of +97%/ +146% and not too far from the SPY’s returns of +149%/ +197% over the same time, respectively.

MDLZ’s dividend investment thesis remains more than safe as well, with a TTM Interest Coverage of 10.80x and a TTM Dividend Coverage Ratio of 2.03x, compared to the sector median of 7.50x/ 2.03x, respectively.

As a result of its well-balanced returns through capital appreciation and dividend income, we will be rating the MDLZ stock as a Buy.

This Buy rating does not come with a specific entry point, since it depends on individual investors’ dollar cost averages and risk appetite, especially given the tremendous recovery by +13% from the recent October 2023 dip.

For now, based on its historical movement thus far, there is a chance that the MDLZ stock may retrace moderately to its previous support level of $64s before bouncing to chart a new top.

As a result of the potential -9% downside, bottom fishing investors may consider waiting for a little longer before adding at those levels for an improved upside potential.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Man charged after alleged bank robberies in ‘old man’ mask
Market & News

Man charged after alleged bank robberies in ‘old man’ mask

November 18, 2026
Grand Theft Auto 6: Reviews come in as worldwide release begins – BBC
Market & News

Grand Theft Auto 6: Reviews come in as worldwide release begins – BBC

November 18, 2026
Current with Christine Romans – Oct. 22 | NBC News NOW
Market & News

Current with Christine Romans – Oct. 22 | NBC News NOW

November 18, 2026
AI model uses facial photos to estimate cancer survival and biological age
Market & News

AI model uses facial photos to estimate cancer survival and biological age

November 18, 2026
Next Post
Rep. Henry Cuellar carjacked outside of his home in D.C.

Rep. Henry Cuellar carjacked outside of his home in D.C.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
King Charles caught without umbrella in rainstorm

King Charles caught without umbrella in rainstorm

November 12, 2026
“Manosphere” that helped Trump could be rethinking

“Manosphere” that helped Trump could be rethinking

November 14, 2026
Quest Diagnostics reports cyber breach affecting ‘certain patient records’

Quest Diagnostics reports cyber breach affecting ‘certain patient records’

November 17, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!